ArticleInternal medicine (Tokyo, Japan)2018

The Efficacy and Safety of Long-term Pirfenidone Therapy in Patients with Idiopathic Pulmonary Fibrosis.

Kazumasa Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.